US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
News Medical on MSN16h
Climate change is pushing up rates of kidney disease and urological cancersClimate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...
An Alabama grandmother who was the first patient to receive a new kind of genetically modified pig kidney more than two months ago is now the longest surviving recipient of a pig organ.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback